Altogether, CD200-CD200R and CX3CL1-CX3CR1 signaling appear to play an important dual and controversial role in neuroprotection and functional recovery; the ability to understand and pharmaceutically manipulate these pathways in an appropriate time window post-infarct could reduce neurological sequelae after stroke. This evidence concerns the gene CX3CL1 and Stroke.